Global Personalized Medicine Diagnostics Market 2012-2016

1

Introduction Aarkstore Enterprise
Our comprehensive and wide range of databank in
the field of Market Research Report provides
exclusive, pioneering and innovative service to
our report buyers. Our high-quality databank
comprises of company profiles, strategy review,
company report, industry reports, company
financials, SWOT analysis, and industry research.
Aarkstore.com is in the forefront as it is
enriched with comprehensive informative and
interactive search features. One can browse to
have ample access of beyond 2.5 lakh business
industry reports.
2
Global Personalized Medicine Diagnostics Market
2012-2016 at Aarkstore.com http//www.aarkstore.c
om/reports/Global-Personalized-Medicine-Diagnostic
s-Market-2012-2016-296021.html

Report
3
Published Date 26 July 2013 Pages  111 PDF
-   3000 You can also request for
sample page of above mention reports on
sample_at_aarkstore.com
4
TechNavios analysts forecast the Global
Personalized Medicine Diagnostics market to grow
at a CAGR of 4.43 percent over the period
2012-2016. One of the key factors contributing to
this market growth is the increasing demand for
personalized medicine for treating cancer. The
Global Personalized Medicine Diagnostics market
has also been witnessing an increase in the
number of industrial activities. However, the low
awareness of personalized medicine diagnostics in
developing countries could pose a challenge to
the growth of this market. TechNavios report,
the Global Personalized Medicine Diagnostics
Market 2012-2016, has been prepared based on an
in-depth market analysis with inputs from
industry experts. The report covers the market in
the Americas, and the EMEA and APAC regions it
also covers the Global Personalized Medicine
Diagnostics market landscape and its growth
prospects in the coming years. The report also
includes a discussion of the key vendors
operating in this market.The key vendors
dominating this space include Abbott
Laboratories, Agilent Technologies Inc., Becton
Dickinson and Company, bioMerieux SA, Illumina
Inc., and Roche Holding AG.The other vendors
mentioned in this report are 20/20 GeneSystems
Inc., Accumetrics Inc., AdvanDx Inc., Affymetrix
Inc., Almac Group Ltd., AltheaDx Inc., Ambry
Genetics Corp., Amgen Inc., Arrayit Corp.,
AssureRx Health Inc., Autogenomics Inc., BG
Medicine Inc., Biocare Medical LLC, Biocartis SA,
Biocept Inc., BioCurex Inc., Biodesix Inc.,
Bio-Reference Laboratories Inc., CombiMatrix
Corp., Corgenix Medical Corp., DxTerity
Diagnostics Inc., EnzoBiochem Inc., Epigenomics
AG, Euroimmun AG, GE Healthcare, Genomic Health
Inc., Interleukin Genetics Inc., Johnson
Johnson, Knome Inc., Lab21 Ltd., Life
Technologies Corp., MDxHealth SA, Myriad Genetics
Inc., Nanosphere Inc., Pathway Genomics Corp.,
Power3 Medical Products Inc., Quest Diagnostics
Inc., Response Genetics Inc., Rosetta Genomics
Ltd., Sequenom Inc., Trovagene Inc., Vermillion
Inc., and Viracor-IBT Laboratories Inc..Key
questions answered in this reportWhat will the
market size be in 2016 and what will be the
growth rate?What are key market trends?What is
driving this market?What are the challenges to
market growth?Who are the key vendors in this
market space?What are the market opportunities
and threats faced by key vendors?What are the
strengths and weaknesses of each of these key
vendors?You can request one free hour of our
analysts time when you purchase this market
report. Details provided within the report.